IL-10R Blockade during Chronic Schistosomiasis Mansoni Results in the Loss of B Cells from the Liver and the Development of Severe Pulmonary Disease

被引:52
作者
Fairfax, Keke C. [1 ,2 ]
Amiel, Eyal [2 ]
King, Irah L. [2 ]
Freitas, Tori C. [2 ]
Mohrs, Markus [2 ]
Pearce, Edward J. [1 ,2 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA
[2] Trudeau Inst, Saranac Lake, NY USA
关键词
MURINE SCHISTOSOMIASIS; MACROPHAGE ACTIVATION; IMMUNE-RESPONSES; HEPATIC-FIBROSIS; VASCULAR-DISEASE; INFECTED MICE; PLASMA-CELLS; TNF-ALPHA; EXPRESSION; DIFFERENTIATION;
D O I
10.1371/journal.ppat.1002490
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In schistosomiasis patients, parasite eggs trapped in hepatic sinusoids become foci for CD4(+) T cell-orchestrated granulomatous cellular infiltrates. Since the immune response is unable to clear the infection, the liver is subjected to ongoing cycles of focal inflammation and healing that lead to vascular obstruction and tissue fibrosis. This is mitigated by regulatory mechanisms that develop over time and which minimize the inflammatory response to newly deposited eggs. Exploring changes in the hepatic inflammatory infiltrate over time in infected mice, we found an accumulation of schistosome egg antigen-specific IgG1-secreting plasma cells during chronic infection. This population was significantly diminished by blockade of the receptor for IL-10, a cytokine implicated in plasma cell development. Strikingly, IL-10R blockade precipitated the development of portal hypertension and the accumulation of parasite eggs in the lungs and heart. This did not reflect more aggressive Th2 cell responsiveness, increased hepatic fibrosis, or the emergence of Th1 or Th17 responses. Rather, a role for antibody in the prevention of severe disease was suggested by the finding that pulmonary involvement was also apparent in mice unable to secrete class switched antibody. A major effect of anti-IL-10R treatment was the loss of a myeloid population that stained positively for surface IgG1, and which exhibited characteristics of regulatory/anti-inflammatory macrophages. This finding suggests that antibody may promote protective effects within the liver through local interactions with macrophages. In summary, our data describe a role for IL-10-dependent B cell responses in the regulation of tissue damage during a chronic helminth infection.
引用
收藏
页数:13
相关论文
共 70 条
[1]   Modulating macrophage function with IgG immune complexes [J].
Anderson, CF ;
Gerber, JS ;
Mosser, DM .
JOURNAL OF ENDOTOXIN RESEARCH, 2002, 8 (06) :477-481
[2]  
Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101
[3]   Cutting edge:: Biasing immune responses by directing antigen to macrophage Fcγ receptors [J].
Anderson, CF ;
Mosser, DM .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :3697-3701
[4]   IL-10 and TGF-β control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice [J].
Anderson, Charles F. ;
Lira, Rosalia ;
Kamhawi, Shaden ;
Belkaid, Yasmine ;
Wynn, Thomas A. ;
Sacks, David .
JOURNAL OF IMMUNOLOGY, 2008, 180 (06) :4090-4097
[5]   Memory B cells are biased towards terminal differentiation: A strategy that may prevent repertoire freezing [J].
Arpin, C ;
Banchereau, J ;
Liu, YJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (06) :931-940
[6]  
Berek C, 1997, Semin Immunol, V9, P261, DOI 10.1006/smim.1997.0076
[7]   Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-γ, high TNF-α, or low RANTES, depending on age and gender [J].
Booth, M ;
Mwatha, JK ;
Joseph, S ;
Jones, FM ;
Kadzo, H ;
Ireri, E ;
Kazibwe, F ;
Kemijumbi, J ;
Kariuki, C ;
Kimani, G ;
Ouma, JH ;
Kabatereine, NB ;
Vennervald, BJ ;
Dunne, DW .
JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :1295-1303
[8]  
BOROS DL, 1982, J IMMUNOL, V128, P1050
[9]   IL-10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni [J].
Bosshardt, SC ;
Freeman, GL ;
Secor, WE ;
Colley, DG .
PARASITE IMMUNOLOGY, 1997, 19 (08) :347-353
[10]  
Brunet LR, 1997, J IMMUNOL, V159, P777